Trial intelligence / Profile preview

Psilocybin-assisted PEARL Therapy for Caregivers of Advanced Cancer Patients

NCT07048743Phase 2Recruiting

Sponsor
University Health Network
Start
Jul 2025
Primary completion
Dec 2027
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of psilocybin, sponsored by University Health Network. Started Jul 2025; status: recruiting.

02

Drugs

psilocybin

Beyond the preview

Go deeper on NCT07048743.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07048743.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call